Eurofarma Laboratorios S.A. clinical trial pipeline

3 trials changed in the last 30 days: 2 stopped, 1 with a notable change, 0 with minor changes only.

1. Stopped

   ATHESA · Fixed-dose Combination of an Angiotensin Receptor…ATHESA · Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension

   Withdrawn before enrolling

   Eurofarma Laboratorios S.A.·Phase 3· NCT06608472· Registry history of NCT06608472 on ClinicalTrials.gov (opens the registry)

   Sep 22, 2026

2. Stopped

   FORASMA · Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma…FORASMA · Formoterol 6 mcg/Fluticasone 125 mcg by Eurofarma Laboratórios S.A. Versus Alenia® 6 mcg/200 mcg · Asthma (FORASMA)

   Withdrawn before enrolling

   Eurofarma Laboratorios S.A.·Phase 3· NCT07318350· Registry history of NCT07318350 on ClinicalTrials.gov (opens the registry)

   Sep 22, 2026

3. Notable

   PANDORA · New Antiandrogenic Progestogen + Low-dose Estrogen for…PANDORA · New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris

   Primary endpoint(s) modified

   Also in this update: Recruitment opened

   Eurofarma Laboratorios S.A.·Phase 3· NCT06905210· Registry history of NCT06905210 on ClinicalTrials.gov (opens the registry)

   Sep 22, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.